Related Experiment Videos
[Anti-arrhythmia effectiveness of potassium-magnesium-aspartate infusion]
P Kühn1, G Oberthaler, J Oswald
1II. Interne Abteilung, Barmherzige Schwester , Linz.
Insights
Potassium-magnesium-aspartate effectively reduced ventricular ectopic beats in patients with ventricular arrhythmias. This cardiac medication showed a significant decline in arrhythmia frequency within one hour, with sustained effects for up to ten hours.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Ventricular arrhythmias pose a significant risk for cardiac events.
- Current treatments for ventricular arrhythmias have limitations.
Purpose:
- To evaluate the efficacy of intravenous potassium-magnesium-aspartate in managing ventricular arrhythmias.
Summary:
- Intravenous potassium-magnesium-aspartate was administered to 21 patients diagnosed with ventricular arrhythmias.
- A significant reduction in the frequency of ventricular ectopic beats was observed one hour post-infusion.
- The therapeutic effect peaked between the sixth and seventh hours and persisted up to ten hours.
Impact:
- Potassium-magnesium-aspartate demonstrates potential as a therapeutic agent for ventricular arrhythmias.
- This finding may lead to improved management strategies for patients with cardiac rhythm disturbances.
Abstract:
In 21 patients with ventricular arrhythmias we analysed the effect of an intravenous infusion of potassium-magnesium-aspartate. It could be demonstrated that the frequency of ventricular ectopic beats significantly declined 1 hour after starting the medication. The maximum effect occurred at the 6th and 7th hour and continued until the 10th hour after starting the medication.